Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in


July 2013 Onwards
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
01 Jul 2013 - 02 Jul 2013
London, UK
Pharmacokinetics in Drug Development - for the Non-Specialist
More information
A lesson for cell-signaling studies using advanced detection techniques
02 Jul 2013 - 02 Jul 2013
A lesson for cell-signaling studies using advanced detection techniques
More information
08 Jul 2013 - 10 Jul 2013
Boston, MA, USA
10th Anti-infectives Partnering and Deal-Making Conference
More information
08 Jul 2013 - 09 Jul 2013
Las Vegas, NV , USA
Pharmaceutical Sales & Brand Management Conference
More information
08 Jul 2013 - 09 Jul 2013
Boston, MA, USA
Pharmaceutical Sales & Brand Management Conference 
More information
08 Jul 2013 - 08 Jul 2013
London, UK
Pediatric Drug Development
More information
10 Jul 2013 - 12 Jul 2013
Le Palais des Congres, Paris, France
WIN 2013 Symposium
More information
11 Jul 2013 - 11 Jul 2013
London, UK
Social Media for Pharmaceutical Marketing
More information
05 Aug 2013 - 09 Aug 2013
Stockton, CA (near San Francisco, CA)
Mass Spectrometry Principles and Practice
More information
<< 1 2 3 4 5 6 7 >>

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos